Expression of ST3Gal, ST6Gal, ST6GalNAc and ST8Sia in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Glycoconjugate Journal

• Publication date

  2015-01-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10719-014-9569-zPMID 25572164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.

  2014cited by this paper
• Characterization of P1 promoter activity of the β-galactoside α2,6sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines

  2012cited by this paper
• Accumulation of Unusual Gangliosides GQ3 and GP3 in Breast Cancer Cells Expressing the GD3 Synthase

  2012cited by this paper
• Characterization of P1 promoter activity of the beta-galactoside alpha2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines.

  2012cited by this paper
• Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways

  2011cited by this paper
• Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.

  2011cited by this paper
• Correlation between Heterogeneous Expression of Sialyltransferases and MUC16 in Ovarian Tumor Tissues

  2011cited by this paper
• Different Expression of ST3Gal and ST6Gal mRNA Between Mouse Hepatocellular Carcinoma Cell Lines

  2011cited by this paper
• Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells*

  2011cited by this paper
• Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6-sialylated blood group type 2H (ST2H) antigen.

  2010cited by this paper
• Glycoprofiling Investigation of Hepatocellular Carcinoma Cell Surface With Lectin Microarray*: Glycoprofiling Investigation of Hepatocellular Carcinoma Cell Surface With Lectin Microarray*

  2010cited by this paper
• Glycoprofiling Investigation of Hepatocellular Carcinoma Cell Surface With Lectin Microarray

  2010cited by this paper
• Overexpression of ST6GalNAcV, a ganglioside-specific α2,6-sialyltransferase, inhibits glioma growth in vivo

  2010cited by this paper
• Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.

  2009cited by this paper
• Ganglioside GM 3 inhibits VEGF / VEGFR-2-mediated angiogenesis : Direct interaction of GM 3 with VEGFR-2

  2009cited by this paper
• Conflict of interest statement. None declared.

  2008cited by this paper
• Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.

  2008cited by this paper
• Ganglioside GM2-Tetraspanin CD82 Complex Inhibits Met and Its Cross-talk with Integrins, Providing a Basis for Control of Cell Motility through Glycosynapse*

  2007cited by this paper
• Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers.

  2007cited by this paper
• The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer*

  2006cited by this paper
• Interleukin‐1β induces sialyl Lewis X on hepatocellular carcinoma HuH‐7 cells via enhanced expression of ST3Gal IV and FUT VI gene

  2006cited by this paper
• The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags.

  2005cited by this paper
• Role of the Human ST6GalNAc-I and ST6GalNAc-II in the Synthesis of the Cancer-Associated Sialyl-Tn Antigen

  2004cited by this paper
• Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.

  2004cited by this paper
• Expression of β-galactoside α2,6 sialyltransferase and of α2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis

  2003cited by this paper
• Sialidase and malignancy: A minireview

  2003cited by this paper
• Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands

  2002cited by this paper
• Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.

  2001cited by this paper
• Influence of cellular ganglioside depletion on tumor formation.

  2000cited by this paper
• Diseases of abnormal protein glycosylation: an emerging area.

  1998cited by this paper
• Mouse β-galactoside α2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression

  1997cited by this paper
• Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.

  1997cited by this paper
• Molecular cloning and expression of Galβ1,3GalNAcα2,3‐sialyltransferase from mouse brain

  1993cited by this paper
• Molecular cloning and expression of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain.

  1993cited by this paper
• Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation.

  1989cited by this paper
• Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion.

  1987cited by this paper
• Letter: Does T4 toxicosis exist?

  1975cited by this paper

• MicroRNA-135b mainly functions as an oncogene during tumor progression.

  2024cites this paper
• Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma

  2023cites this paper
• Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives

  2021cites this paper
• Comprehensive quali-quantitative profiling of neutral and sialylated O-glycome by mass spectrometry based on oligosaccharide metabolic engineering and isotopic labeling

  2019cites this paper
• Enhanced expression of α2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.

  2017cites this paper
• Upregulation of microRNA‐135b and microRNA‐182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway

  2017cites this paper
• Overexpression of sT3gal-i promotes migration and invasion of hcclM3 in vitro and poor prognosis in human hepatocellular carcinoma

  2016cites this paper
• Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma

  2016cites this paper
• Oncotargets and Therapy Dovepress Dovepress Overexpression of St3gal-i Promotes Migration and Invasion of Hcclm3 in Vitro and Poor Prognosis in Human Hepatocellular Carcinoma Qing-jie Song

  year unknowncites this paper